4,226 followers
@DovePress: Omalizumab, an anti-immunoglobulin E antibody: state of the art. FULL TEXT! http://t.co/okiZokzbxD #RespEd
@DovePress: Omalizumab, an anti-immunoglobulin E antibody: state of the art. FULL TEXT! http://t.co/okiZokzbxD #RespEd
“@AllergyNet: Omalizumab. The breakthrough allergy drug of the last decade. Open access http://t.co/91nHVPY0Rs Very expensieve in NL
Omalizumab. The breakthrough allergy drug of the last decade. Open access http://t.co/hhhY5roPMP
Omalizumab, an anti-immunoglobulin E antibody: state of the art http://t.co/FKb4Wf6smt